StockData
CLCSOTCPharmaceutical PreparationsFiscal year ends December 31

Cell Source, Inc.

Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 14, 2026
$0.49−0.00 (-0.01%)

Close on Oct 19, 2026

Market cap
$21.99M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Cell Source has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Cell Source filed with the SEC